SBIR-STTR Award

Airway Area By Acoustic Reflectometry
Award last edited on: 1/8/09

Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$811,695
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Gary M Glass

Company Information

E Benson Hood Laboratories Inc (AKA: Hood Labs)

575 Washington Street
Pembroke, MA 02359
   (781) 826-7573
   customerservice@hoodlabs.com
   www.hoodlabs.com
Location: Single
Congr. District: 09
County: Plymouth

Phase I

Contract Number: 1R43HL055139-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1996
Phase I Amount
$81,079
This Phase I application deals with non-invasive acoustic imaging of the hypopharyngeal, laryngeal and pulmonary airways. Images of airway cross sectional area as a function of axial distance along the airway are reconstructed from amplitudes and arrival times of acoustic returns measured at the airway opening. Although this imaging technology has been shown to be accurate, to require little or no subject cooperation and to have a number of important diagnostic applications, its broader applicability in the pulmonary clinic has been limited by the requirement of the use of gas mixtures with high acoustic wavespeed, such as 20% O2- 80% He, as a result of a fundamental acoustical constraint. The objective of this application is to show the feasibility of a method that circumvents that constraint, and, thereby, permits this technology to be employed reliably using air as the acoustic propagation medium within the patient's airways. Such a technical simplification would find diagnostic and screening applications not only in the research laboratory, but also in the clinical laboratory and the ICU. A secondary but important objective is to combine this technology with the simultaneous measurement of respiratory flows. This is important because many of the pathologies of interest manifest themselves as an inappropriate degree of dynamic airway collapse that occurs only in the presence of a sufficiently large inspiratory (obstructive sleep apnea) or expiratory (tracheo-malacia) flow. Because this technology requires little contact time and little or no subject cooperation, it might become particularly useful in the pediatric clinic and the neonatal ICU.Proposed commercial application:Noninvasive imaging of extent and locus of airways obstruction. Established diagnostic applications include: reactive airways disease, asthma, disorders of airway growth, tracheal stenosis, obstructive sleep apnea. Potential diagnostic applications include indication for surgery and post-surgical evaluation in velopharyngeal incompetence, obstructive sleep apnea, vocal cord dysfunction, tracheal stenosis, tracheal reconstruction, preoperative sizing of endotracheal tubes.National Institute of Heart, Lung, and Blood Institute (NHLBI)

Phase II

Contract Number: 2R44HL055139-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1997
(last award dollars: 1998)
Phase II Amount
$730,616

This Phase II application deals with non-invasive acoustic imaging of the oropharynx, hypopharynx, and larynx. Images of cross sectional area of the airway lumen as a function of axial distance along the airway are reconstructed from amplitudes and arrival times of acoustic returns measured at the airway opening. Although this imaging technology has been shown to be accurate, to require little or no subject cooperation, and to have important research applications, it has been too complicated to be used as a practical screening tool because it required the use of gas mixtures with high acoustic wavespeed, such as 20% 02-80% He. as a result of a fundamental acoustical constraint. In Phase I we established the feasibility of a new technical approach that circumvents that constraint, thereby simplifying the technology and allowing it to be employed using ordinary room air as the acoustic propagation medium. We established also in Phase I the feasibility of combining this technology with the simultaneous measurement of respiratory flows. Our aims for Phase II are. 1) to implement and refine the new technology and 2) to validate its utility as a screening tool. In Phase Il we focus this technology on two clinical circumstances that result in significant adverse outcomes with high prevalence: endotracheal intubation failure and obstructive sleep apnea. These circumstances were selected because the societal impact of the technology is expected to be immediate and because the associated commercial potential is thought to be large.Proposed commercial application:Noninvasive imaging of extent and locus of airways obstruction. Established diagnostic applications include: reactive airways disease, asthma, disorders of airway growth, tracheal stenosis, obstructive sleep apnea. Potential diagnostic applications include indication for surgery and post- surgical evaluation in velopharyngeal incompetence. obstructive sleep apnea. vocal cord dysfunction. tracheal stenosis, tracheal reconstruction, preoperative assessment of difficult intubation.Thesaurus termsbiomedical equipment development, diagnosis design /evaluation, reflection spectrometry, respiratory airflow measurement, respiratory disorder diagnosis, respiratory visualization clinical biomedical equipment, computer program /software, computer system design /evaluation, noninvasive diagnosis, respiratory airflow disorder, sound clinical research, human subjectNational Heart, Lung and Blood Institute (NHLBI)